Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
55
Publications avec texte intégral
Open Access
46 %
Mots clés
Cardiomyopathy
Chronicity
BAFF
Ferrites
Immune regulation
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Experimental autoimmune myasthenia gravis
Acetylcholine receptor antibodies
Disease susceptibility
Neuromuscular junction
Early-onset myasthenia gravis
Myasthenia Gravis MG
Exercise
Transcriptome
Clinical cell transplantation
Myasthenia gravis
MYB
Etiology
Macrophages
DICER
Inflammation
Ectopic germinal centers
B cells
Th17 cells
Inflammatory cytokines
Immune response
Long-term follow-up
Glucocorticoids
Gd T cells
Immunotherapy
COVID-19
Myoblasts
Max
Auto-immunité
Chemokines
MiR-125
PBMC
Genetic associations
Complete Freund's adjuvant
CXCL13-CXCR5
Acetylcholine receptor
Thymus
Experimental mouse models
Acetylcholine receptors
Gender
CTCF
Germinal center
Genetics
Adaptive immunity
Innate immunity
MG patients
Centres germinatifs ectopiques
Anticorps monoclonal
FMR1
Immunology and Microbiology Section
Germinal centers
Chemokine
Endogenous nucleic acids
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Autoimmunity
AChR antibodies
Interferon type I
Il-23
Thymic epithelial cells
Interleukine-23
Lamin A/C nuclei
Mass cytometry CyTOF
Fragile X syndromes
CD31
LMNA
Human myoblasts
Chronic inflammation
Experimental autoimmune myasthenia gravis EAMG
Heart failure
Thymoma
Interferon type-I
Antimir-150
Acides nucléiques endogènes
Animal models
COX2
Myasthénie grave
Interferon de type I
Interleukin 23
Cellules th17
Conduction disease
Quality of life
CCL21
Interferon IFN
Autoimmune diseases
Experimental models
Immunity
Cytokines
Autoimmune disease
Interferon
M3243AG
Interféron de type I
Interferon-β
MiR-7
Interferonopathy
Maladie auto-immune